Drug Markets/Dexlansoprazole

Dexlansoprazole

15 NDCs across 5 manufacturers|12 Generic,3 Brand

Dexlansoprazole is used to treat peptic esophagitis, gastroesophageal reflux and heartburn, per the National Library of Medicine's MED-RT classification.

▸ More about this market

The brand product was first FDA-approved on Jan 30, 2009, and the first generic was approved Apr 19, 2017. FDA's Orange Book lists 10 AB-rated (therapeutically equivalent) products for this ingredient. In 2024, Medicare Part D spent $262 million on Dexlansoprazole across 883,000 claims for 196,000 beneficiaries.

Dexlansoprazole is available as 15 NDCs from 5 manufacturers (12 generic, 3 brand), with NADAC prices from $3.72 to $9.84 per EA — the most expensive product costs about 2.6× the cheapest. Every pack size and labeler in this drug market is compared side-by-side below.

Total NDCs

15

12G / 3B

Manufacturers

5

competing in market

Price Spread

$3.72 – $9.84

per EA

7d Activity

12↑3↓0 flat

avg +1.5% WoW · of 15 NDCs

Market Price Trend

Monthly average NADAC per unit, split by generic and brand.

Explore this market from other angles

Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.

Drug Portfolio

15 NDCs total, 15 shown

WatchDrug ↕Price 7d Change ↕
DEXILANT DR 30 MG CAPSULE
$9.8399
per EA
-0.05%
DEXILANT DR 60 MG CAPSULE
$9.8366
per EA
-0.01%
DEXILANT DR 60 MG CAPSULE
$9.8366
per EA
-0.01%
DEXLANSOPRAZOLE DR 60 MG CAP
$3.8341
per EA
+2.00%
DEXLANSOPRAZOLE DR 60 MG CAP
$3.8341
per EA
+2.00%
DEXLANSOPRAZOLE DR 60 MG CAP
$3.8341
per EA
+2.00%
DEXLANSOPRAZOLE DR 60 MG CAP
$3.8341
per EA
+2.00%
DEXLANSOPRAZOLE DR 60 MG CAP
$3.8341
per EA
+2.00%
DEXLANSOPRAZOLE DR 60 MG CAP
$3.8341
per EA
+2.00%
DEXLANSOPRAZOLE DR 60 MG CAP
$3.8341
per EA
+2.00%
DEXLANSOPRAZOLE DR 60 MG CAP
$3.8341
per EA
+2.00%
DEXLANSOPRAZOLE DR 30 MG CAP
$3.7171
per EA
+1.70%
DEXLANSOPRAZOLE DR 30 MG CAP
$3.7171
per EA
+1.70%
DEXLANSOPRAZOLE DR 30 MG CAP
$3.7171
per EA
+1.70%
DEXLANSOPRAZOLE DR 30 MG CAP
$3.7171
per EA
+1.70%

Frequently Asked Questions

What is Dexlansoprazole used to treat?

Dexlansoprazole is used to treat peptic esophagitis, gastroesophageal reflux and heartburn, per the National Library of Medicine's MED-RT classification.

When did Dexlansoprazole become available as a generic?

FDA approved the first generic Dexlansoprazole (ANDA) on Apr 19, 2017. The Orange Book currently lists 10 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.

How much does Medicare spend on Dexlansoprazole?

In 2024, Medicare Part D spent $262 million on Dexlansoprazole across 883,000 claims for 196,000 beneficiaries.

How many Dexlansoprazole products are on the market?

The Dexlansoprazole drug market contains 15 NDCs from 5 manufacturers — 12 generic and 3 brand products.

What is the price range for Dexlansoprazole?

NADAC reference prices for Dexlansoprazole range from $3.7171 to $9.8399 per EA — the most expensive product costs about 2.6× the cheapest.

Is generic Dexlansoprazole cheaper than brand?

The average generic NADAC for Dexlansoprazole is $3.7951 per EA, versus $9.8377 for brand-labeled products — brand versions average about 2.6× the generic price.

Which manufacturers make Dexlansoprazole?

5 manufacturers list Dexlansoprazole in NADAC. Ranked by number of NDCs, the largest are Takeda Pharmaceuticals America, Inc. (3), Upsher-Smith Laboratories LLC (3), Endo USA Inc. (3), Mylan Pharmaceuticals Inc. (3), Alembic Pharmaceuticals Inc. (3).

How has the price of Dexlansoprazole changed recently?

Over the past 7 days, 12 Dexlansoprazole NDCs rose and 3 fell, with a market-wide average change of +1.5%.